Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Nathan H. Parker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8947-7942; OpenAlex author ID A5064138486; NIH RePORTER profile ID 15278553. Sources: ClinicalTrials.gov.

Their work

Papers
25 (first author 5, last author 0)
Trials
1 (principal investigator on 1)
Grants
1
Labs led
1
Collaborators
83
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 4 papers · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers, 1 trial, 1 grant · 2025: 4 papers · 2026: 3 papers

Papers 25

  1. Aerobic Exercise Activates S1PR1 Signaling in Tumor Endothelial Cells to Promote Vascular Function in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-4733↗
  2. Exercise Modulates Microbial Metabolites and Induces Stromal Remodeling in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-5143↗
  3. Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630. Co-author DOI 10.3390/cancers18050789↗
  4. Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43856-025-01277-9↗
  5. The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1055-9965.epi-25-0237↗
  6. Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study … Co-author DOI 10.1371/journal.pone.0322192↗
  7. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Co-author DOI 10.3390/cancers17040630↗
  8. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A st… Co-author DOI 10.1016/j.conctc.2024.101271↗
  9. Response to: Comment on "Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreati… First author DOI 10.1097/as9.0000000000000435↗
  10. Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of t… Co-author DOI 10.3389/fonc.2024.1362244↗
  11. Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Ran… First author DOI 10.1097/sla.0000000000005878↗
  12. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.006↗
  13. The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment. Co-author DOI 10.1177/1534735420986615↗
  14. Factors Influencing Exercise Following Pancreatic Tumor Resection. Co-author DOI 10.1245/s10434-020-09062-9↗
  15. ASO Author Reflections: It is Time to Prioritize Exercise in Pancreatic Cancer Survivorship. Co-author DOI 10.1245/s10434-020-09091-4↗
  16. Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1002/cam4.2157↗
  17. Physical activity and exercise during preoperative pancreatic cancer treatment. Co-author DOI 10.1007/s00520-018-4493-6↗
  18. Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study. Co-author DOI 10.1123/jpah.2019-0027↗
  19. Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life. First author DOI 10.1177/1534735419894061↗
  20. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. Co-author DOI 10.1007/s11605-017-3618-4↗
  21. Home-based exercise during preoperative therapy for pancreatic cancer. First author DOI 10.1007/s00423-017-1599-0↗
  22. Poster 68 Feasibility of a Prehabilitation Program for Patients with Potentially Resectable Pancreatic Cancer: Pilot Study. First author DOI 10.1016/j.pmrj.2016.07.111↗
  23. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/pas.0000000000000491↗
  24. Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-014-4285-2↗
  25. Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. Co-author DOI 10.1016/j.jamcollsurg.2014.02.023↗

Trials 1

  1. Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer Principal investigator NCT06423963↗

Grants 1

  1. Tele-resistance training during chemotherapy for advanced upper gastrointestinal cancer K22CA262352↗

Closest collaborators

The 25 strongest of 83 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. An Ngo‐Huang · 17 shared papers, 2015–2026 · strength 2.43
  2. Matthew H. G. Katz · 18 shared papers, 2014–2026 · strength 2.17
  3. Keri Schadler · 10 shared papers, 2017–2026 · strength 1.41
  4. Maria Q. B. Petzel · 13 shared papers, 2015–2026 · strength 1.37
  5. Pamela Joy Hodul · 3 shared papers, 1 shared trial, 2024–2025 · strength 1.15
  6. Jeffrey E. Lee · 10 shared papers, 2014–2023 · strength 0.76
  7. Jason B. Fleming · 9 shared papers, 2014–2025 · strength 0.72
  8. Laura R. Prakash · 6 shared papers, 2015–2026 · strength 0.70
  9. Karen M. Basen-Engquist · 6 shared papers, 2019–2023 · strength 0.63
  10. Andrew Eugene Hendifar · 2 shared papers, 2025–2026 · strength 0.62
  11. Andrew L. Coveler · 2 shared papers, 2025–2026 · strength 0.62
  12. Philip J. Chang · 2 shared papers, 2025–2026 · strength 0.62
  13. Gillian K. Gresham · 2 shared papers, 2025–2026 · strength 0.62
  14. Paul E. Oberstein · 2 shared papers, 2025–2026 · strength 0.62
  15. David R. Fogelman · 9 shared papers, 2014–2019 · strength 0.61
  16. Sumedha Pareek · 3 shared papers, 2022–2026 · strength 0.54
  17. Florencia M. McAllister · 3 shared papers, 2022–2026 · strength 0.54
  18. Riccardo Ballarò · 2 shared papers, 2026 · strength 0.42
  19. Robin D. Wright · 2 shared papers, 2026 · strength 0.42
  20. Eduardo D Bruera · 4 shared papers, 2017–2023 · strength 0.38
  21. Sarah M. Judge · 2 shared papers, 2025 · strength 0.31
  22. Daniel K. Jeong · 2 shared papers, 2025 · strength 0.31
  23. Andrew R. Judge · 2 shared papers, 2025 · strength 0.31
  24. Dung‐Tsa Chen · 2 shared papers, 2025 · strength 0.31
  25. Evan W. Davis · 2 shared papers, 2025 · strength 0.31

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.